1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Epiomic Epidemiology Series: Angina Pectoris Forecast in 8 Major Markets 2015-2025

Epiomic Epidemiology Series: Angina Pectoris Forecast in 8 Major Markets 2015-2025

  • September 2015
  • -
  • Black Swan Analysis Ltd132
  • -
  • 50 pages

Summary

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Angina Pectoris in 8 Major Markets

Angina Pectoris is the term given to the pain or discomfort felt when the heart muscle lacks an adequate supply of oxygen rich blood (ischaemia). The main cause of angina is coronary arterial disease (CAD), which is the obstruction of coronary arteries due to build up of atherosclerotic plaque. Other forms of angina include microvascular angina (MVD) also known as Cardiac Syndrome X. This report provides the current prevalent population for Angina Pectoris across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of course of progression, coronary vessels affected and associated co-morbidities of Angina Pectoris. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Angina Pectoris have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Angina Pectoris include:

-Diabetes
-Hypertension
-Dyslipidemia
-Chronic heart failure
-Peripheral artery disease
-Erectile dysfunction
-Aortic valve sclerosis

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

-Able to quantify patient populations in global Angina Pectoris’s market to target the development of future products, pricing strategies and launch plans.
-Gain further insight into the prevalence of the subdivided types of Angina Pectoris and identify patient segments with high potential.
-Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
-Provide a level of understanding on the impact from specific co-morbid conditions on Angina Pectoris’s prevalent population.
-Identify sub-populations within Angina Pectoris which require treatment.
-Gain an understanding of the specific markets that have the largest number of Angina Pectoris patients.

Table Of Contents

Epiomic Epidemiology Series: Angina Pectoris Forecast in 8 Major Markets 2015-2025
Angina Pectoris
Table of Contents
-List of Tables and Figures
-Introduction
-Cause of the Disease
-Risk Factors and Prevention
-Diagnosis of the Disease
-Variation by Geography/Ethnicity
-Disease Prognosis andClinical Course
-Key Co-morbid Conditions /Features Associated with the Disease
-Methodology for Quantification of Patient Numbers
-Top-Line Prevalence for Angina Pectoris
-Features of Angina Patients
o Course of Progression of Angina
o Degree of Coronary Artery Disease in Angina Patients
o Angina Patients and BMI
o CACS in Angina Patients
o Vessels Affected in Angina Patients with Significant CAD
o Angina Grades of Affected Vessel(s)
-Associates Co-morbid Conditions of Angina
-Abbreviations and Acronyms used in the Report
-Other Black Swan Analysis Publications
-Black Swan Analysis Online Patient-Based Databases
-Patient-Based Offering
-Online Pricing Data and Platforms
-References
-Appendix


List of Figures
-Canadian Cardiovascular Society (CCS) classification of Angina

List of Tables
-Prevalence of Angina, total (000s)
-Prevalence of Angina, males (000s)
-Prevalence of Angina, females (000s)
-The course of Angina in Angina patients, total (000s)
-Type of chest pain observed in Angina patients, total (000s)
-Angina patients by degree of CAD involvement, total (000s)
-BMI status of Angina patients, total (000s)
-CACS in Angina patients, total (000s)
-Number of vessels affected by CAD in Angina patients, total (000s)
-Location of the vessel affected by CAD in Angina patients, total (000s)
-CCS Angina grade of single vessel CAD Angina patients, total (000s)
-CCS Angina grade of double vessel CAD Angina patients, total (000s)
-CCS Angina grade of triple vessel CAD Angina patients, total (000s)
-Prevalence of Diabetes in Angina patients, total (000s)
-Diabetes by degree of CAD involvement in Angina patients, total (000s)
-Prevalence of Hypertension in Angina patients, total (000s)
-Hypertension by degree of CAD involvement in Angina patients, total (000s)
-Prevalence of PAD in Angina patients, total (000s)
-CCS Angina Grade of PAD in Angina patients, total (000s)
-Erectile dysfunction in Angina patients, males (000s)
-Angina patients with a history of stroke by CCS class, total (000s)
-Chronic Heart failure (CHF) in Angina patients by CCS class, total (000s)
-Abbreviations and Acronyms used in the report
-USA Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
-USA Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
-France Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
-France Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
-Germany Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
-Germany Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
-Italy Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
-Italy Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
-Spain Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
-Spain Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
-United Kingdom Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
-United Kingdom Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
-Brazil Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
-Brazil Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)
-Japan Prevalence of Angina Pectoris by 5-yr age cohort, males (000s)
-Japan Prevalence of Angina Pectoris by 5-yr age cohort, females (000s)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Chronic Stable Angina-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Chronic Stable Angina-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Chronic Stable Angina-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Angina (Angina Pectoris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Angina (Angina Pectoris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Angina (Angina Pectoris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

 Chronic Stable Angina-Pipeline Insights, 2016

Chronic Stable Angina-Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “ Chronic Stable Angina-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Chronic Stable Angina. The ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.